NCT03884556 2025-07-02TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced CancersTrishula Therapeutics, Inc.Phase 1 Completed56 enrolled 19 charts
NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled